Acumen Pharmaceuticals, Inc.ABOSNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank20
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
-100.14%
↓ 63% vs avg
Percentile
P20
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-61.54%
Historical baseline
PeriodValue
2024-100.14%
2023-22.01%
2022-96.18%
2021-141.62%
2020-9.27%
20190.00%